213 related articles for article (PubMed ID: 18561895)
1. Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: the role of p53 and p21.
Escandell JM; Kaler P; Recio MC; Sasazuki T; Shirasawa S; Augenlicht L; Ríos JL; Klampfer L
Biochem Pharmacol; 2008 Jul; 76(2):198-207. PubMed ID: 18561895
[TBL] [Abstract][Full Text] [Related]
2. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
Sun J; Blaskovich MA; Jove R; Livingston SK; Coppola D; Sebti SM
Oncogene; 2005 May; 24(20):3236-45. PubMed ID: 15735720
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors induce cell death selectively in cells that harbor activated kRasV12: The role of signal transducers and activators of transcription 1 and p21.
Klampfer L; Huang J; Shirasawa S; Sasazuki T; Augenlicht L
Cancer Res; 2007 Sep; 67(18):8477-85. PubMed ID: 17875686
[TBL] [Abstract][Full Text] [Related]
4. Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21.
El-Khatib M; Geara F; Haddadin MJ; Gali-Muhtasib H
Radiat Oncol; 2010 Nov; 5():107. PubMed ID: 21078189
[TBL] [Abstract][Full Text] [Related]
5. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
[TBL] [Abstract][Full Text] [Related]
6. Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin.
Ravizza R; Gariboldi MB; Passarelli L; Monti E
BMC Cancer; 2004 Dec; 4():92. PubMed ID: 15601469
[TBL] [Abstract][Full Text] [Related]
7. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
8. Role of p21 as a determinant of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl] diamantane response in human HCT-116 colon carcinoma cells.
Wang JJ; Hung HF; Huang ML; Lee HJ; Chern YT; Chang YF; Chi CW; Hsu YC
Oncol Rep; 2012 Feb; 27(2):529-34. PubMed ID: 22076474
[TBL] [Abstract][Full Text] [Related]
9. Quinacrine-mediated autophagy and apoptosis in colon cancer cells is through a p53- and p21-dependent mechanism.
Mohapatra P; Preet R; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN
Oncol Res; 2012; 20(2-3):81-91. PubMed ID: 23193914
[TBL] [Abstract][Full Text] [Related]
10. Killing of Kras-mutant colon cancer cells via Rac-independent actin remodeling by the βGBP cytokine, a physiological PI3K inhibitor therapeutically effective in vivo.
Mallucci L; Shi DY; Davies D; Jordan P; Nicol A; Lotti L; Mariani-Costantini R; Verginelli F; Wells V; Zicha D
Mol Cancer Ther; 2012 Sep; 11(9):1884-93. PubMed ID: 22752425
[TBL] [Abstract][Full Text] [Related]
11. The Mutant KRAS Gene Up-regulates BCL-XL Protein via STAT3 to Confer Apoptosis Resistance That Is Reversed by BIM Protein Induction and BCL-XL Antagonism.
Zaanan A; Okamoto K; Kawakami H; Khazaie K; Huang S; Sinicrope FA
J Biol Chem; 2015 Sep; 290(39):23838-49. PubMed ID: 26245900
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic reovirus preferentially induces apoptosis in KRAS mutant colorectal cancer cells, and synergizes with irinotecan.
Maitra R; Seetharam R; Tesfa L; Augustine TA; Klampfer L; Coffey MC; Mariadason JM; Goel S
Oncotarget; 2014 May; 5(9):2807-19. PubMed ID: 24798549
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of p21WAF1 sensitizes cells to apoptosis via an increase of both p14ARF and p53 levels and an alteration of the Bax/Bcl-2 ratio.
Javelaud D; Besancon F
J Biol Chem; 2002 Oct; 277(40):37949-54. PubMed ID: 12151395
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibitory effect of Cucurbitacin E on breast cancer cells.
Lan T; Wang L; Xu Q; Liu W; Jin H; Mao W; Wang X; Wang X
Int J Clin Exp Pathol; 2013; 6(9):1799-805. PubMed ID: 24040444
[TBL] [Abstract][Full Text] [Related]
15. Ras association domain family 1 isoform A suppresses colonic tumor cell growth through p21
Oh SJ; Lee MG; Moon JR; Lee CK; Chi SG; Kim HJ
J Gastroenterol Hepatol; 2019 May; 34(5):890-898. PubMed ID: 30226276
[TBL] [Abstract][Full Text] [Related]
16. p53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells.
Aneja R; Ghaleb AM; Zhou J; Yang VW; Joshi HC
Cancer Res; 2007 Apr; 67(8):3862-70. PubMed ID: 17440101
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer.
Shangary S; Ding K; Qiu S; Nikolovska-Coleska Z; Bauer JA; Liu M; Wang G; Lu Y; McEachern D; Bernard D; Bradford CR; Carey TE; Wang S
Mol Cancer Ther; 2008 Jun; 7(6):1533-42. PubMed ID: 18566224
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of pancreatic cancer cell growth by cucurbitacin B through modulation of signal transducer and activator of transcription 3 signaling.
Zhang M; Sun C; Shan X; Yang X; Li-Ling J; Deng Y
Pancreas; 2010 Aug; 39(6):923-9. PubMed ID: 20182390
[TBL] [Abstract][Full Text] [Related]
19. The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells.
Yang H; Xiang S; Kazi A; Sebti SM
J Biol Chem; 2020 Mar; 295(10):3055-3063. PubMed ID: 32001619
[TBL] [Abstract][Full Text] [Related]
20. TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers.
Singh A; Sweeney MF; Yu M; Burger A; Greninger P; Benes C; Haber DA; Settleman J
Cell; 2012 Feb; 148(4):639-50. PubMed ID: 22341439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]